Consistently, by exposing hepatocytes and KCs to cholesterol crystals, NLRP3 inflammasome activation was demonstrated to be involved in the development of NASH (81). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.